A Study of AK0529 in Chinese Infants Hospitalized With RSV

Clinical trial NCT04231968 · COMPLETED

Trial details

NCT number: NCT04231968
Sponsor: Shanghai Ark Biopharmaceutical Co., Ltd.
Status: COMPLETED
Phase: Phase 3
Study type: INTERVENTIONAL

Respiratory Syncytial Virus Infections

Start date: 2020-09-22
Primary completion: 2022-01-21
Enrollment: 311

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.